Eyelid solution

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Care Pharmaceuticals Pty Ltd

clase:

Class I

Fabricado por:

Schalcon Spa Via Di Saponara 614, Rome, 00125 Italy

Área terapéutica:

58837 - Eyelid solution

indicaciones terapéuticas:

A liposomal phospholipid suspension intended to be applied to the eyelids for the treatment and relief of symptoms of dry, itchy and irritated eyes due to tear film deficiencies through the provision of supplemental lipids on the eyelid margin to stabilize the natural tear film lipid layer.

Estado de Autorización:

A

Fecha de autorización:

2014-12-01